Circassia Pharmaceuticals (GB:NIOX) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Circassia Pharmaceuticals, a medical device company focused on asthma diagnosis, has announced a proposal to return up to £21 million to its shareholders through a Tender Offer for up to 26,250,000 Ordinary Shares at a price of 80 pence each. This price is at a premium of over 21% compared to recent average share prices, with the offer representing about 6.2% of the company’s issued share capital. Qualifying shareholders have the option to sell back a portion of their shares, and the company will retain the first 10 million shares bought back in treasury.
For further insights into GB:NIOX stock, check out TipRanks’ Stock Analysis page.
